SureTrader SureTrader
Home > Boards > US OTC > Biotechs >

Mymetics Corporation (MYMX)

MYMX RSS Feed
Add MYMX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/22/2016 2:45:48 PM - Followers: 14 - Board type: Free - Posts Today: 0

                                                              MYMX Website http://www.mymetics.com/


Mymetics is an international biotechnology company successfully focused on developing vaccines and therapies to combat AIDS.
Mymetics was founded in 1990 near Lyon, France and was registered as a US (Delaware) public company in 2000. Since August 2003, its operations and research programs have been managed out of Switzerland (Nyon, near Geneva).

 

Most recent news headlines

  • Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model.
  • Mymetics Also Announces Deal for Vaccine Delivery System
  • Mymetics' Novel HIV Vaccine to Begin New NIH-Funded Study at University of California, Davis
  • Mymetics' Respiratory Syncytial Virus (RSV) Vaccine Protects From Viral Challenge in Pre-Clinical Study
  • Mymetics' Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response in Children in Tanzania(Market Wire)

Results from last trial Taken from MYMX Website www.mymetics.com

Mymetics performed a 12 months pre-clinical trial at ILAS (Institute of Animal Laboratory Science) in Beijing, China.

The study involved several groups of female Chinese macaques, which received multiple challenges with the live virus. The results could not have been more convincing: The group that was vaccinated with Mymetics' preventive HIV vaccine candidate showed 100% protection, while the non-vaccinated control group was fully infected. These ground breaking scientific results have been presented at key world leading HIV congresses and have triggered strong attention from the HIV scientific community and foundations.
See more

 


 

FROM LATEST PR

Mymetics Corporation (OTCBB: MYMX), a pioneer in the development of vaccines preventing mucosal transmission of human infectious diseases, announced today that its innovative HIV vaccine will enter a new preclinical trial at the University of California, Davis. The study will be led by Professor Christopher J. Miller of the California National Primate Research Center, a leader in immunodeficiency virus transmission in nonhuman primate models, and partially funded by the NIH (National Institutes of Health). It follows a recently completed smaller study at the Institute of Laboratory Animal Science (ILAS) in Beijing, China in which the vaccine provided an unprecedented 100% protection in macaque monkeys. The vaccine is also currently in a Phase I trial in human volunteers.


From June PR's

  • Mymetics' Respiratory Syncytial Virus (RSV) Vaccine Protects From Viral Challenge in Pre-Clinical Study

7:13a ET June 28, 2010 (Market Wire)

Mymetics Corporation (OTCBB: MYMX), a pioneer in the development of vaccines preventing early transmission of human infectious diseases, announced today that a pre-clinical study on its Respiratory Syncytial Virus (RSV) vaccine showed protection against a live virus challenge, and a paper reporting these results has now been accepted for publication by the leading scientific journal Vaccine.


  • Mymetics' Phase Ib Malaria Vaccine: Safe, Well Tolerated and Long-Lasting Antibody Response
     Children in Tanzania

7:10a ET June 17, 2010 (Market Wire)

Mymetics Corporation, a pioneer in the development of vaccines preventing early transmission of human infectious diseases, announced today that its innovative Malaria vaccine has successfully completed a Phase Ib clinical trial in Tanzania. The study confirms that the company's virosome-based vaccine is well tolerated and safe for adults and children as young as 5 years of age. The vaccine induced specific, long-lasting antibody responses against the key AMA-1 and CSP-1 Malaria antigens in semi-immune subjects, lasting up to 12 months for CSP-1.

 


                                                                           From The Mymetics website

                                                                                                           

 


 

                                                                                                                        
                                           Share Structure:

  •                     June 30, 2010 (From 10-q filed 8-23)
  •                                 --------------------------------------------------------------------------
  •                        
  •                     196,263,630 Issued and outstanding

 


 

                                                                                           

  •  

Thank you for reading, if you found this Ibox helpful please feel free to give me a person mark and or board mark if there is anything i missed that should be added or anything that should be changed, feel free to send me a msg. If you are interested in becoming an Assist on this board just let me know.

happy trading and good luck to all.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MYMX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
MYMX News: Quarterly Report (10-q) 08/12/2016 10:29:22 AM
MYMX News: Quarterly Report (10-q) 05/12/2016 02:55:20 PM
PostSubject
#522   Glad to inform my fellow investors. corpus 09/22/16 02:45:48 PM
#521   Thanks for the heads up. I check this tyfoidhana 09/19/16 08:08:51 PM
#520   NEWS!!! MYMETICS and TEXAS BIOMED CONTINUE COLLABORATION for corpus 09/19/16 12:09:11 PM
#519   I strongly believe a new partner will emerge corpus 09/19/16 12:04:23 PM
#518   I agree door is wide open. tyfoidhana 09/18/16 03:50:50 PM
#517   MYMETICS' RSV vaccine gets a good chance while corpus 09/16/16 11:37:36 AM
#516   We got a new web site this year tyfoidhana 09/08/16 08:25:20 PM
#515   <<< Company Overview >>> for new/potential investors. corpus 09/08/16 12:49:01 PM
#514   Mymetics' upcoming events http://www.mymetics.com/media-center/events corpus 08/29/16 02:46:30 PM
#513   Nice find Harrey. So...basically they added a third corpus 07/25/16 12:09:53 PM
#512   This is a recent article that mentions Ruth Harry Wickey 07/22/16 11:07:04 AM
#511   Article published by Dr. Ruth Ruprecht in the corpus 06/09/16 11:10:07 PM
#510   From THE BILL & MELINDA GATES FOUNDATION***** corpus 06/04/16 02:48:09 PM
#508   MYMETICS included here! corpus 05/26/16 04:54:47 PM
#507   MMs are just waiting for the assault johnstockmaster 04/19/16 09:50:16 AM
#506   Trading under other ticker in another country? Is Fibanotch 04/13/16 02:52:10 PM
#505   ...This company does Not know how to make Fibanotch 04/13/16 02:33:35 PM
#504   When I say this is huge I mean tyfoidhana 04/12/16 10:00:55 PM
#503   The market surely does not think so. Harry Wickey 04/12/16 07:33:15 PM
#502   This is huge! Between HIV and Malaria tyfoidhana 04/11/16 09:42:23 PM
#501   Eyes are looking Mymetics now for sure. Front corpus 04/11/16 02:09:32 PM
#500   From 10K again, Harry Wickey 04/11/16 12:33:24 PM
#499   I agree this is a significant success. Harry Wickey 04/11/16 11:06:59 AM
#498   HIV result with Texas Biomed has been corpus 04/11/16 09:55:37 AM
#497   Swiss Biotech posted the news front page. corpus 04/06/16 04:22:24 PM
#496   Your welcome. This successful study will be presented corpus 04/06/16 09:32:27 AM
#495   Nice call Harry tyfoidhana 04/05/16 08:51:47 PM
#494   Thanks for the heads up Corpus really great tyfoidhana 04/05/16 08:47:18 PM
#493   Significantly reduce (97-100%) the transmission of Plasmodiun falciparum para corpus 04/05/16 07:15:35 PM
#492   Malaria Transmission-Blocking virosome based vaccine's preclinical trial is corpus 04/05/16 09:17:38 AM
#491   So far so good. 10-k is awesome! A corpus 03/24/16 07:12:14 PM
#490   The 10K has been released about a week Harry Wickey 03/24/16 12:27:31 PM
#489   I don't believe a large part of the tyfoidhana 03/14/16 08:38:14 PM
#488   Not to sure on time frame, but studies Harry Wickey 03/12/16 07:56:37 PM
#487   In 3-4 weeks? How sure are you? corpus 03/11/16 07:16:26 PM
#486   This stock will be a lot higher or Harry Wickey 03/11/16 01:31:13 PM
#485   May the monkeys live long and healthy, and tyfoidhana 03/04/16 08:32:41 PM
#484   Mymetics' Upcoming Events corpus 03/03/16 11:29:06 AM
#483   From The Bill&Melinda Gates Foundation website: corpus 03/02/16 05:04:44 PM
#482   Any luck contacting them? Did you get an answer? corpus 02/24/16 03:05:31 PM
#481   Ok...I'm going to dust this off from 2013 TheSaint09 02/21/16 12:25:11 PM
#480   This one has serious credibility and great potential IMO tyfoidhana 02/21/16 11:14:39 AM
#479   Me to I never heard it. tyfoidhana 02/20/16 02:12:35 AM
#478   What happened to the rumor? Just curious... corpus 02/16/16 02:31:42 PM
#477   Interesting read, were on the list like to tyfoidhana 02/09/16 10:21:34 PM
#476   Read what Dr. Thomas Monath (remember him?) is corpus 02/09/16 05:10:40 PM
#475   "Mymetics is currently evaluating new possible partnerships around corpus 02/04/16 02:55:08 PM
#474   ***$MYMX NOW LISTED ON IHUB ZIKA BOARD*** GhostInTheMatrix 02/01/16 04:55:16 PM
#473   Beginning a study on zika virus! Sleeper, should northandsouth1 02/01/16 10:01:08 AM
#472   Harry, you're right. That paragraph needs to be corpus 01/29/16 03:17:44 PM
PostSubject